Key Moments
373 – Thyroid function & hypothyroidism: how new approaches are transforming care
Key Moments
Thyroid hormone basics, the role of deiodinases, and modern approaches to diagnosing and treating hypothyroidism.
Key Insights
Thyroid hormone (T4) is a prohormone converted to the active form (T3) by deiodinase enzymes in tissues, allowing for local regulation of hormone activity.
TSH is a crucial pituitary hormone that stimulates thyroid function, but it's not the sole indicator of thyroid health; free T4 and T3 levels are also vital.
Fasting can significantly alter thyroid hormone levels, prioritizing energy conservation by reducing T3 production and increasing reverse T3.
Different deiodinase enzymes (D1, D2, D3) play distinct roles in activating or inactivating thyroid hormones, with D2 being highly efficient in converting T4 to T3 in key tissues like the brain.
Standard T3 and reverse T3 assays can be unreliable, motivating the adoption of mass spectrometry for more accurate measurements.
Hypothyroidism is far more common than hyperthyroidism, with Hashimoto's disease being the leading autoimmune cause.
Treatment of hypothyroidism primarily involves T4 monotherapy, but combination therapy with T3 or desiccated thyroid extract may benefit some patients.
The diagnosis of hypothyroidism relies on TSH and free T4 levels, with symptoms alone being insufficient due to their non-specific nature.
Excessive iodine intake can trigger autoimmune thyroid disease.
Future advancements in thyroid care may include slow-release T3 formulations and improved diagnostic assays.
THYROID HORMONE PHYSIOLOGY AND REGULATION
The thyroid gland produces thyroxine (T4), an inactive prohormone, which is converted to the active triiodothyronine (T3) by deiodinase enzymes in target tissues. This conversion allows for localized control of thyroid hormone action, as receptors have a higher affinity for T3. The hypothalamus and pituitary gland regulate thyroid function via the hypothalamic-pituitary-thyroid axis, with TSH stimulating thyroid hormone production. T4 has a long half-life, providing a stable circulating level, while T3 has a short half-life, enabling rapid modulation of cellular activity. This system evolved to conserve iodine, crucial for hormone synthesis.
THE ROLE OF DEIODINASE ENZYMES
Deiodinase enzymes are central to thyroid hormone metabolism. Type 1 deiodinase (D1), found in the liver and kidneys, is sensitive to carbohydrate intake and plays a role in both T3 production from T4 and the clearance of reverse T3. Type 2 deiodinase (D2), highly efficient, is crucial for generating T3 in tissues like the brain, hypothalamus, and pituitary, where it converts T4 to T3 to regulate TSH feedback. Type 3 deiodinase (D3) inactivates thyroid hormones, converting T4 to reverse T3 and T3 to T2, acting as a protective mechanism to set local thyroid hormone levels.
DIAGNOSTIC CHALLENGES AND LAB INTERPRETATION
Diagnosing thyroid dysfunction relies on TSH and free T4 measurements, with free T3 and reverse T3 being valuable for assessing deiodinase activity. However, T3 and reverse T3 immunoassays can have significant variability, making mass spectrometry a preferred method for accuracy. During fasting or illness, the body prioritizes energy conservation by reducing T3 and T4, increasing reverse T3, and TSH may be inappropriately normal or slightly elevated. Understanding these physiological responses is critical to avoid misdiagnosis in non-standard conditions.
HYPERTHYROIDISM AND HYPOTHYROIDISM: CAUSES AND DIFFERENCES
Hyperthyroidism, characterized by excessive thyroid hormone, is less common and often caused by Graves' disease (autoimmune stimulation) or thyroid nodules. Symptoms include palpitations, weight loss, and agitation. Hypothyroidism, far more prevalent, is typically caused by Hashimoto's disease, an autoimmune condition where antibodies destroy the thyroid gland, leading to insufficient hormone production. Symptoms can include fatigue, weight gain, and cognitive impairment. While TSH is a key diagnostic marker, free T4 is essential, and symptoms alone are not diagnostic due to their non-specific nature.
TREATMENT STRATEGIES FOR HYPOTHYROIDISM
The standard treatment for hypothyroidism is levothyroxine (T4) monotherapy, which aims to normalize TSH and free T4. However, a significant portion of patients remain symptomatic or do not achieve optimal biochemical control, suggesting incomplete restoration of thyroid hormone economy. Combination therapy with T4 and T3, either through synthetic T3 or desiccated thyroid extract (DTE), may offer benefits for these individuals. DTE, derived from pig thyroids, contains both T4 and T3 in a natural ratio, and studies suggest it can lead to better patient preference and outcomes compared to T4 monotherapy.
ADVANCEMENTS AND FUTURE DIRECTIONS IN THYROID CARE
While current treatments normalize TSH for most patients, there's a recognized need for improved therapeutic strategies. Future directions include developing more reliable T3 assays (mass spectrometry), creating slow-release T3 formulations to mimic natural secretion, and investigating the role of T3 in reducing mortality and improving metabolic health. The understanding that hypothyroidism can be a significant risk factor for cardiovascular disease highlights the importance of comprehensive management beyond just TSH normalization. Continued research into thyroid hormone physiology and its impact on various bodily systems is crucial for advancing patient care.
Mentioned in This Episode
●Supplements
●Companies
●Organizations
●Books
●Concepts
●People Referenced
Thyroid Hormone Properties and Half-Lives
Data extracted from this episode
| Hormone | Activity/Form | Iodine Atoms | Half-Life |
|---|---|---|---|
| T4 (Thyroxine) | Inactive prohormone | 4 | ~8 days |
| T3 (Triiodothyronine) | Active form | 3 | ~12 hours |
| Reverse T3 (rT3) | Inactive form | 3 (from inner ring) | Few hours (shorter than T3) |
Deiodinase Enzyme Activity
Data extracted from this episode
| Enzyme | Primary Function | Efficiency for T4 | Tissue Location/Sensitivity |
|---|---|---|---|
| D1 (Type 1 Deiodinase) | Activates T4 to T3, clears rT3 | Lousy (low affinity) | Liver, Kidneys; sensitive to insulin/carbohydrates |
| D2 (Type 2 Deiodinase) | Activates T4 to T3 | Superb (1000-fold more affinity than D1) | Hypothalamus, Pituitary Gland, Brown Fat; produces ~80% of T3 outside thyroid |
| D3 (Type 3 Deiodinase) | Inactivates T3 to T2, T4 to rT3 | High affinity for T3 | Generally inactivates thyroid hormone |
Thyroid Disorder Prevalence (US Adult Population)
Data extracted from this episode
| Condition | Estimated Cases | Prevalence |
|---|---|---|
| Hypothyroidism | ~20 million | 4-5% |
| Hyperthyroidism | Few hundred thousand | <0.1% (rarer) |
Mortality in Hypothyroidism Treatment
Data extracted from this episode
| Treatment | Mortality Relative to Healthy Controls | Relative Reduction vs. Levothyroxine |
|---|---|---|
| Levothyroxine (T4 monotherapy) | 2.5 times greater | N/A |
| Combination Therapy (T4/T3) | Elevated (but reduced) | 30% reduction |
Common Questions
The thyroid gland takes up iodine from the blood to produce thyroid hormones. Primarily it produces inactive T4, which is then converted into the active T3 in various tissues throughout the body.
Topics
Mentioned in this video
An inactive form of T3, produced when iodine is removed from the inner ring of T4. It has minimal activity at the receptor and a very short half-life.
The active form of thyroid hormone, created by removing one iodine atom from T4. It binds to thyroid receptors with high affinity and has a short half-life of about 12 hours.
An inactive prohormone produced by the thyroid gland, containing four iodine atoms. It has a long half-life of about 8 days and is a precursor to T3.
A steroid used to reduce TPO antibody levels in certain infertility cases, where positive TPO antibodies might be implicated despite normal thyroid function.
A synthetic T3 hormone, approved by the FDA but rarely used as monotherapy due to its short half-life and potential for rapid energy bursts.
A natural thyroid hormone replacement derived from dried pig thyroid glands, containing both T4 and T3. It has been used for over a century and is subject to FDA recalls.
A synthetic T4 hormone, widely used as the standard of care for hypothyroidism. It has a long half-life and is taken once a day.
Enzymes that remove iodine atoms from T4 to produce T3 (active) or reverse T3 (inactive), playing a crucial role in regulating thyroid hormone activity at the tissue level.
A hormone produced by the pituitary gland, stimulated by TRH from the hypothalamus. TSH encourages the thyroid to produce and secrete T4.
More from Peter Attia MD
View all 125 summaries
135 min381‒Alzheimer’s disease in women: how hormonal transitions impact the brain, new therapies, & more
9 minIs Industrial Processing the Real Problem With Seed Oils? | Layne Norton, Ph.D.
13 minCooking with Lard vs Seed Oils | Layne Norton, Ph.D.
146 min380 ‒ The seed oil debate: are they uniquely harmful relative to other dietary fats?
Found this useful? Build your knowledge library
Get AI-powered summaries of any YouTube video, podcast, or article in seconds. Save them to your personal pods and access them anytime.
Try Summify free